News

Major gaps in Canada’s rules for high-security labs, federal experts warned

OTTAWA — Canada’s push to build a domestic pharmaceutical industry and prepare for future pandemics is running into a problem: the same federal government that wants top-end biology research here doesn’t yet have the capacity to make sure that work is done in safe and secure laboratories.

    Subscribe now to start reading premium, award-winning journalism.

    By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.

    In-depth, agenda-setting reporting

    Great journalism delivered straight to your inbox.

    A Virginia neighbourhood with a cluster of buildings that are the newly built Amazon Web Services data centres in the background.

    Briefing

    OpenAI adds Microsoft as non-voting member

    TD Bank to cut 3% of its workforce amid profit slump

    Canadian energy companies face pressure to cut emissions as COP28 begins

    Best business newsletter in Canada

    Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.

    Exclusive events

    See the bigger picture with reporters and industry experts in subscriber-exclusive events.

    Membership in The Logic Council

    Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.

    Canada's most influential executives and policymakers are reading The Logic

    • CPP Investments
    • Sun Life Financial
    • C100
    • Amazon
    • Telus
    • Mastercard
    • bdc
    • Shopify
    • Rogers
    • RBC
    • General Motors
    • MaRS
    • Government of Canada
    • Uber
    • Loblaw Companies Limited